Abiomed (FRA:AIO) Additional Paid-In Capital : €914 Mil(As of Sep. 2022)

View and export this data going back to 1987. Start your Free Trial

What is Abiomed Additional Paid-In Capital?

Abiomed's quarterly additional paid-in capital increased from Mar. 2022 (€790 Mil) to Jun. 2022 (€837 Mil) and increased from Jun. 2022 (€837 Mil) to Sep. 2022 (€914 Mil).

Abiomed's annual additional paid-in capital increased from Mar. 2020 (€669 Mil) to Mar. 2021 (€673 Mil) and increased from Mar. 2021 (€673 Mil) to Mar. 2022 (€790 Mil).

Abiomed Additional Paid-In Capital Historical Data

The historical data trend for Abiomed's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abiomed Additional Paid-In Capital Chart

Abiomed Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Additional Paid-In Capital

Get a 7-Day Free Trial

502.74

611.10

668.92

672.58

790.03

Abiomed Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Additional Paid-In Capital	Get a 7-Day Free Trial															714.33	755.09	790.03	837.18	913.80

Abiomed Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Abiomed Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Abiomed's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Abiomed (FRA:AIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abiomed Inc (FRA:AIO) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

22 Cherry Hill Drive, Danvers, MA, USA, 01923

Website

https://www.abiomed.com

Abiomed Inc provides temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.